Peer reviewed
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.
PubMed / NCBIPublished 2022-10Accessed Aug 2, 2026
Registry record
Source metadata
- Publisher
- PubMed / NCBI
- Source type
- Peer reviewed
- Registry ID
pubmed-selank-morphine-withdrawal-2022- DOI
- 10.1007/s10517-022-05624-x
- PMID
- 36322304
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.